IL-17 Inhibition: A Targeted Approach to the Management of Psoriatic Arthritis

This program which includes an interactive video module downloadable slides and a ClinicalThought commentary provides expert perspectives on approved and investigational IL-17&ndash targeted therapies for treating psoriatic arthritis.

Share

Program Content

Supporters

Supported by an educational grant from

Lilly USA